John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 55,699 shares at $17.64 ($983K) on 2023-12-07, disclosed to the SEC on 2023-12-11.
Scheduled sale ($983k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.54 | 7,380 | $129K | 13.2% |
| 2 | $17.54 | 7,380 | $129K | 13.2% |
| 3 | $17.64 | 13,017 | $230K | 23.4% |
| 4 | $17.64 | 13,017 | $230K | 23.4% |
| 5 | $17.75 | 6,702 | $119K | 12.1% |
| 6 | $17.75 | 6,702 |
| $119K |
| 12.1% |
| 7 | $17.81 | 1,501 | $27K | 2.7% |
| Total | $17.64 avg | 55,699 | $983K | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |